CoChat

Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine

Kavalali, Ege T., Monteggia, Lisa M. · 2012 · American Journal of Psychiatry

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Recent clinical studies have demonstrated that a single subpsychotomimetic dose of ketamine, an ionotropic glutamatergic N-methyl-D-aspartate (NMDA) receptor antagonist, produces a rapid antidepressant response in patients with major depressive disorder, with effects lasting up to 2 weeks. Despite enthusiasm about this unexpected efficacy of ketamine, its widespread use as a fast-acting antidepressant in routine clinical settings is curtailed by its abuse potential as well as possible psychotomimetic effects. However, the ability of ketamine to produce a rapid and long-lasting antidepressant response in patients with depression provides a unique opportunity for investigation of mechanisms that mediate these clinically relevant behavioral effects. From a mechanistic perspective, it is easy to imagine how activation of NMDA receptors may trigger cellular and behavioral responses; it is relatively more difficult, however, to envision how transient blockade of one of the key pathways for neuronal communication produces a persistent beneficial effect. The authors discuss recent work linking ketamine's mechanism of action to homeostatic synaptic plasticity processes activated after suppression of NMDA-mediated glutamatergic neurotransmission. They focus on their recent work demonstrating that ketamine-mediated blockade of NMDA receptors at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase, resulting in reduced eEF2 phosphorylation and desuppression of rapid dendritic pr…

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2012.12040531

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 48 references

Research works printed but not linked: 2

  1. Schwartz PH, 1991, Res Commun Chem Pathol Pharmacol, 73, 181
  2. Gómez-Galán M, Mol Psychiatry

Cited by

See all 276

Metadata

Authors
Kavalali, E. T., & Monteggia, L. M.
Affiliations
The University of Texas Southwestern Medical Center (US)
Venue
American Journal of Psychiatry
Published
2012-11
Volume
169
Issue
11
Pages
1150-1156
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2124203952
Cited by
258
References
48
Citations by year
2026: 11 · 2025: 17 · 2024: 10 · 2023: 11 · 2022: 16 · 2021: 18 · 2020: 11 · 2019: 19 · 2018: 15 · 2017: 17 · 2016: 20 · 2015: 27 · 2014: 31 · 2013: 31 · 2012: 2
FWCI
3.37
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (MH 070727, R01MH066198, MH-066198, R01MH070727)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
ketamine, major depressive disorder, NMDA receptor antagonism, homeostatic plasticity, eEF2K, eEF2 phosphorylation, brain-derived neurotrophic factor, glutamatergic neurotransmission, presynaptic neurotransmitter release, rapid-acting antidepressants
MeSH terms
Animals, Antidepressive Agents, Brain, Disease Models, Animal, Humans, Ketamine, Synaptic Transmission, Neuronal Plasticity, Synapses, Synaptic Vesicles, Signal Transduction, Receptors, N-Methyl-D-Aspartate, Neurotransmitter Agents, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine. https://app.cochat.ai/papers/10.1176/appi.ajp.2012.12040531
The paper
Kavalali, E. T., & Monteggia, L. M. (2012). Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2012.12040531

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.